Structure Therapeutics Inc.

GPCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$37.08

+$0.27 (+0.73%)

Sep 22, 2026, 9:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022
Cash & Equivalents	272.64M	316.17M	799.62M	102.91M	147.02M	152.12M	169.51M	172.13M	381.63M	97.83M	129.79M	50.64M	40.59M	126.49M	26.09M	28.09M
Short-Term Investments	1.07B	1.14B	646.57M	696.13M	639.47M	684.76M	714.01M	743.16M	545.49M	338.62M	337.53M	154.79M	184M	114.37M	64.75M	74.66M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	41M	5.56M	717K	6.6M	6.2M	6.1M	5.11M	1.82M	1.83M	47K	45K	350K	38K	59K	3.46M	2.27M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	29.37M	32.09M	124.11M	14.98M	12.8M	12.74M	7.69M	8.37M	10.5M	12.91M	6.29M	4.54M	3.64M	5.29M	2.25M	n/a
Total Current Assets	1.37B	1.49B	1.57B	814.02M	799.3M	849.62M	891.21M	923.65M	937.62M	449.36M	473.61M	209.96M	228.22M	246.16M	93.09M	104.77M
Property-Plant & Equipment	12.39M	11.97M	12.9M	11.54M	10.94M	10.83M	7.01M	7.74M	7.58M	7.82M	8.36M	6.06M	1.17M	1.14M	1.29M	1.37M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	53.39M	17.53M	13.62M	18.14M	17.15M	16.93M	12.12M	9.57M	9.41M	7.87M	8.41M	6.41M	1.21M	1.2M	4.76M	3.64M
Total Assets	1.43B	1.51B	1.58B	832.16M	816.44M	866.55M	903.33M	933.22M	947.03M	457.23M	482.02M	216.37M	229.43M	247.35M	97.85M	108.41M
Account Payables	11.13M	7.82M	13.86M	17.8M	8.99M	8.71M	8.02M	8.45M	2.21M	6.54M	4.74M	3.32M	5.7M	4.95M	6.01M	5.7M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	6.37M	12.43M	8.55M	5.59M	4.75M	7.29M	6.11M	4.01M	2.05M	4.33M	3.39M	2.25M	1.28M	3.54M	2.76M
Total Current Liabilities	66.11M	56.98M	63.29M	57.53M	39.03M	36.49M	36.02M	33.43M	22.66M	23.59M	24.74M	20.09M	15.01M	11M	13.01M	12.23M
Long-Term Debt	n/a	3.18M	3.61M	4.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.27M	863K	647K	325K	317K	308K	302K	309K	293K	296K	298K	281K	1K	n/a	199.98M	200.09M
Total Long-Term Liabilities	4.9M	4.05M	4.26M	4.61M	5.33M	5.42M	2.47M	2.98M	3.34M	3.82M	4.31M	3.32M	1K	n/a	199.98M	200.09M
Total Liabilities	71.01M	61.03M	67.54M	62.14M	44.36M	41.91M	38.49M	36.42M	26M	27.41M	29.05M	23.41M	15.01M	11M	212.99M	212.32M
Total Debt	6.23M	5.79M	6.49M	7.09M	7.68M	7.59M	3.86M	4.39M	4.67M	5.13M	5.45M	3.85M	73K	168K	260K	330K
Book Value	1.35B	1.45B	1.52B	770.02M	772.08M	824.64M	864.84M	896.8M	921.03M	429.82M	452.97M	192.96M	214.41M	236.35M	-115.14M	-103.91M
Book Value Per Share	18.64	19.98	25.62	13.17	13.33	14.38	15.10	15.68	18.64	9.23	9.76	5.04	5.61	6.32	-3.15	-2.66
Common Stock	21K	21K	21K	18K	17K	17K	17K	17K	17K	14K	14K	11K	10K	11K	1K	1K
Retained Earnings	-652.43M	-546.27M	-470.3M	-503.3M	-437.59M	-375.93M	-329.1M	-292.62M	-258.64M	-232.61M	-206.57M	-182.07M	-158.21M	-134.93M	-116.95M	-105.08M
Comprehensive Income	-3.45M	-2.2M	1.05M	825K	362K	815K	914K	2.84M	-487K	-90K	521K	-310K	-390K	147K	-110K	-135K
Shareholders Equity	1.35B	1.45B	1.52B	770.02M	772.08M	824.64M	864.84M	896.8M	921.03M	429.82M	452.97M	192.96M	214.41M	236.35M	-115.14M	-103.91M
Total Investments	1.07B	1.14B	646.57M	696.13M	639.47M	684.76M	714.01M	743.16M	545.49M	338.62M	337.53M	154.79M	184M	114.37M	64.75M	74.66M